使MALDI-TOF MSCYP21A2

Xiaoshan Yin1, Yiming Lin2, Ting Zhang3

  • 1Department of Genetics and Metabolism, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China; Department of Clinical Psychology, School of Health in Social Science, The University of Edinburg, Edinburg, United Kingdom.

概括

一种新的MALDI-TOF MS测定有效地识别了CYP21A2基因变异和缺失,用于中国先天性上腺增生 (CAH) 查. 这种方法通过检测更多的CAH类型并减少假阳性来改善激素测试.